DK0834314T3 - Granuler der indeholder pranlukast, fremgangsmåde til fremstilling af granulerne, og fremgangsmåde til reduktion af pranlukasts klæbeevne - Google Patents

Granuler der indeholder pranlukast, fremgangsmåde til fremstilling af granulerne, og fremgangsmåde til reduktion af pranlukasts klæbeevne

Info

Publication number
DK0834314T3
DK0834314T3 DK96916361T DK96916361T DK0834314T3 DK 0834314 T3 DK0834314 T3 DK 0834314T3 DK 96916361 T DK96916361 T DK 96916361T DK 96916361 T DK96916361 T DK 96916361T DK 0834314 T3 DK0834314 T3 DK 0834314T3
Authority
DK
Denmark
Prior art keywords
pranlukast
granules
adhesiveness
containing granules
reducing
Prior art date
Application number
DK96916361T
Other languages
English (en)
Inventor
Seiei Minase Res Inst Sasatani
Masashi Minase Res Inst Shiota
Yoshinori Minase Res Inst O Ii
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK0834314T3 publication Critical patent/DK0834314T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK96916361T 1995-06-12 1996-06-11 Granuler der indeholder pranlukast, fremgangsmåde til fremstilling af granulerne, og fremgangsmåde til reduktion af pranlukasts klæbeevne DK0834314T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16929295 1995-06-12
PCT/JP1996/001578 WO1996041628A1 (fr) 1995-06-12 1996-06-11 Granules contenant du pranlukast, procede de production des granules et procede de reduction de la cohesion du pranlukast

Publications (1)

Publication Number Publication Date
DK0834314T3 true DK0834314T3 (da) 2003-02-24

Family

ID=15883819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96916361T DK0834314T3 (da) 1995-06-12 1996-06-11 Granuler der indeholder pranlukast, fremgangsmåde til fremstilling af granulerne, og fremgangsmåde til reduktion af pranlukasts klæbeevne

Country Status (8)

Country Link
US (1) US5876760A (da)
EP (1) EP0834314B1 (da)
KR (1) KR100389606B1 (da)
AT (1) ATE230987T1 (da)
DE (1) DE69625813T2 (da)
DK (1) DK0834314T3 (da)
ES (1) ES2191101T3 (da)
WO (1) WO1996041628A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19617487A1 (de) † 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
TW546151B (en) 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
EA200000956A1 (ru) * 1998-04-18 2001-04-23 Глаксо Груп Лимитед Фармацевтический аэрозольный препарат
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
KR100381834B1 (ko) * 2000-05-20 2003-04-26 이상득 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법
US6692976B1 (en) * 2000-08-31 2004-02-17 Agilent Technologies, Inc. Post-etch cleaning treatment
ATE481968T1 (de) * 2004-07-14 2010-10-15 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung
KR100591786B1 (ko) 2004-10-19 2006-06-26 휴먼팜 주식회사 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법
KR101086254B1 (ko) * 2004-11-04 2011-11-24 에스케이케미칼주식회사 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법
WO2006109737A1 (ja) * 2005-04-11 2006-10-19 Ono Pharmaceutical Co., Ltd. 苦味が低減されたプランルカスト水和物を含有する製剤
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
KR101233235B1 (ko) * 2005-08-26 2013-02-15 에스케이케미칼주식회사 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법
KR100715355B1 (ko) 2005-09-30 2007-05-07 주식회사유한양행 프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법
KR100981751B1 (ko) * 2005-10-28 2010-09-10 주식회사유한양행 프란루카스트를 함유하는 과립 및 그의 제조방법
KR100981750B1 (ko) * 2005-10-28 2010-09-10 주식회사유한양행 분무-건조 과립 및 그의 제조방법
CA2673536A1 (en) * 2006-12-22 2008-07-03 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
KR102363727B1 (ko) 2015-06-01 2022-02-16 삼아제약 주식회사 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
WO1993017709A1 (en) * 1992-03-12 1993-09-16 Ono Pharmaceutical Co., Ltd. Antipruritic
JPH0776516A (ja) * 1993-09-06 1995-03-20 Toyobo Co Ltd 難溶性薬物含有製剤の製造方法

Also Published As

Publication number Publication date
WO1996041628A1 (fr) 1996-12-27
DE69625813D1 (de) 2003-02-20
EP0834314A1 (en) 1998-04-08
US5876760A (en) 1999-03-02
ATE230987T1 (de) 2003-02-15
DE69625813T2 (de) 2003-09-04
EP0834314A4 (en) 2000-05-10
ES2191101T3 (es) 2003-09-01
KR100389606B1 (ko) 2003-09-26
EP0834314B1 (en) 2003-01-15
KR19990022791A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
DK0834314T3 (da) Granuler der indeholder pranlukast, fremgangsmåde til fremstilling af granulerne, og fremgangsmåde til reduktion af pranlukasts klæbeevne
PT797987E (pt) Preparacao granular de libertacao controlada e processo para a sua preparacao
TW367363B (en) Production of anionic surfactant granules
ATE323467T1 (de) Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
AU4913500A (en) Method for producing bead polymers
MY109813A (en) Process of preparing large dimension emulsion polymer particles, polymer product and uses thereof
GB2237578B (en) Artificial stone compositions, process of producing the same and apparatus employed in the production thereof
UA42745C2 (uk) Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин
CA2429412A1 (en) Production of fine-grained particles
HUP0003095A2 (hu) Tabletta alakú mosószer összesajtolt szemcsékből, valamint eljárás előállítására
MY105047A (en) Process for making concentrated surfactant granules.
YU120988A (en) Process for preparing new dispersion pills of cimetidine
HUT54119A (en) Process for producing antiinflammatory aminophenol derivatives
IL124645A0 (en) Process for the production of 1, 2-bis (acyloxylates)
HUP9601358A2 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
CA2230673A1 (en) The production of metal lumps
SE9502941D0 (sv) Förfarande vid framställning av tabletter genom pressning samt tabletter framställda enligt förfarandet
CA2071707A1 (en) Polymer Alloy Material and Process for Production Thereof
MY127455A (en) Granular nonionic detergent composition and process for producing the same
MY117412A (en) Production process of colored fine particulate composition and colored fine particulate composition produced by the process
CA2370145A1 (en) Process of preparing a high-energy softening agent
MY125431A (en) Method for producing a granulate from a melt.
EA199900897A3 (ru) Катализаторы на основе ванадия , их получение и применение при (со) полимеризации альфа-олефинов
FR2689502B1 (fr) Procédé de production de 1, 1-dichloro-1-fluoréthane ("141b") stabilisé et produit obtenu.
MY121212A (en) Granular nonionic detergent composition and process for producing the same